ClinicalTrials.gov
public full text
Public Domain
HIV Vaccine in HIV-uninfected Adults
The purpose of this study is to test whether delayed boosting (an extra administration of a vaccine) with the IHV01 (FLSC) protein and A244/AHFG with or without ALFQ will cause the body to make higher amounts of antibodies or different types of antibodies after the vaccination.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers#967084
- Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection#268066
- Psychosocial and Structural Correlates of Cumulative Antiretroviral Adherence Measured by Tenofovir Diphosphate in Dried Blood Spots Among People With HIV In Cape Town, South Africa#207041
- Feeding-Related Gut Microbial Composition Associates With Peripheral T-Cell Activation and Mucosal Gene Expression in African Infants#1015700
- The Impact of Vaccination on Severity of Illness in COVID-19#1093683
Record · ID 826128
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive